Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.00
Bid: 330.00
Ask: 360.00
Change: 0.00 (0.00%)
Spread: 30.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 345.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year end and COVID 19 trading update

1 May 2020 07:00

RNS Number : 5604L
Cropper(James) PLC
01 May 2020
 

1 May 2020

 

James Cropper plc

("James Cropper" or the "Company")

Year end and COVID 19 trading update

 

Further to its announcement of 24th March, James Cropper is pleased to provide an update on the expected outturn for the year to 28th March 2020 just ended and on our expectations for trading during the current year.

Year ended 28 March 2020

As a result of delivering on the growth strategies within each division, the Group produced a strong performance last year with positive growth in both revenue and profits. Market penetration and expansion has been achieved across the divisions. Adjusted pre-tax profits (excluding IAS 19 impact) are expected to be well ahead of market expectations for that period and in excess of £6m.

Current trading

During the current COVID 19 pandemic, the Company's priorities are the health and well-being of all employees globally, supporting our customers and managing our cash resources.

Whilst the Company was on track to continue growing, the impact from COVID 19 will have a negative effect on product demand in each of our divisions:

· Technical Fibre Products is likely to see a downturn as a result of a decline in the aerospace market; however, growth is continuing in clean technology markets such as fuel cell and wind energy. As a result, we expect demand will not be so significantly affected.

· James Cropper Paper is likely to be the most affected of our divisions in the short term, as end markets have been directly impacted by the global lockdown. As a niche speciality provider, we expect demand and growth to return to normal levels after markets settle post-pandemic.

· Despite the impact from COVID-19, we expect Colourform to grow year-on-year, however not to the levels anticipated initially.

Given the high levels of uncertainty, we are not reasonably able to forecast the impact on our operations and financial performance for the current fiscal year. The environment is subject to rapid change. Nevertheless, at present we are expecting that the course of the financial year will be as follows: the first quarter to June 2020 to incur a large negative impact and it will be loss making. During this period, the Company is making use of the Government's Coronavirus Job Retention Scheme to furlough more than 50% of staff in the UK operations. In the next two quarters, to December 2020, we expect still to see a negative effect and to continue to be loss-making, albeit with some recovery evident. For the final quarter to March 2021, we expect progressive recovery towards a more normalised situation and the Company anticipates being back into profitability. We continue to monitor new information as it becomes available and progress our planning accordingly.

 

 

 

Cash resources and future capex

The business is now, we believe, in an 18-24 month recovery period. The Company expects a hit to cash during 2020-2021over the period of the COVID-19 pandemic and as we return to more normal trading conditions. We have acted promptly to conserve cash and to implement immediate savings to shore up reserves, including announcing that the Board has decided not to pay a final dividend in respect of the year ending 28 March 2020. The Company presently has liquidity of over £12 million including cash and available overdraft facilities which, when taking into account the cash management actions being implemented, is expected to be sufficient to weather the COVID-19 crisis and the return to more normal trading conditions.

The Board, nevertheless, is also considering the funding of its capital expenditure plans post the COVID-19 crisis, which support the future growth of the business. Accordingly, it is in the early stages of discussions with its bank debt providers on potential future facilities.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

Enquiries:

James Cropper PLC (AIM: CRPR)

Phil Wild, CEO

Isabelle Maddock, CFO

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

ENDS

 Shore Capital

Robert Finlay, Henry Willcocks

Anita Ghanekar, John More

Tel: + 44 (0) 207 408 4090

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEESRIIVII
Date   Source Headline
19th Nov 20144:23 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSIssue of equity and director dealings
11th Nov 20147:00 amRNSHalf-year results to 27 September 2014
22nd Sep 20142:29 pmRNSDirector/PDMR Shareholding
8th Sep 201412:53 pmRNSExpansion of production capacity
22nd Aug 201410:44 amRNSAcquisition of shares by Share Incentive Plan
5th Aug 20144:51 pmRNSDirector/PDMR Shareholding
30th Jul 201411:00 amRNSAnnual General Meeting and Trading Update
21st Jul 20145:01 pmRNSDIRECTORS' SHAREHOLDINGS
11th Jul 201412:10 pmRNSDirector/PDMR Shareholding
4th Jul 201411:45 amRNSDirector/PDMR Shareholding
24th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSBoard changes
2nd Jun 20143:41 pmRNSTotal Voting Rights
6th May 20148:53 amRNSIssue of Equity
1st Apr 20147:00 amRNSIssue of Equity
31st Mar 20144:57 pmRNSTotal Voting Rights
4th Mar 20147:00 amRNSIssue of Equity
3rd Mar 20141:38 pmRNSHolding(s) in Company
28th Feb 201411:40 amRNSBoard Change
12th Feb 201410:42 amRNSIssue of Equity
7th Jan 20144:08 pmRNSHolding(s) in Company
2nd Jan 201410:56 amRNSTotal Voting Rights
2nd Jan 20147:00 amRNSBoard appointment
5th Dec 20139:48 amRNSIssue of Equity
5th Dec 20138:18 amRNSDIRECTORS' SHAREHOLDINGS
27th Nov 20137:00 amRNSIssue of Equity
15th Nov 20139:14 amRNSDirector Dealing
12th Nov 20137:00 amRNSHalf-year results to 28 September 2013
1st Oct 201310:07 amRNSHolding(s) in Company
20th Sep 20134:54 pmRNSDirector Dealing
17th Sep 20133:22 pmRNSDirector Dealing
17th Sep 20137:00 amRNSBoard appointment
7th Aug 201311:36 amRNSDirector Dealing
1st Aug 20137:00 amRNSDIRECTORS' SHAREHOLDINGS
31st Jul 201311:00 amRNSAnnual General Meeting and Trading Update
23rd Jul 20135:18 pmRNSDirector/PDMR Shareholding
17th Jul 20137:00 amRNSNew Recycling Technology Developed
4th Jul 20137:00 amRNSIssue of Equity
25th Jun 20137:00 amRNSPrelim Results for the year ended 30 March 2013
29th May 201311:46 amRNSBoard change
24th May 201311:27 amRNSBoard changes
2nd Apr 201312:42 pmRNSTotal Voting Rights
28th Mar 20137:00 amRNSIssue of Equity
20th Mar 201311:09 amRNSHolding(s) in Company
19th Mar 201311:31 amRNSDirector Shareholding
15th Mar 20137:00 amRNSIssue of Equity
8th Mar 20134:31 pmRNSHolding(s) in Company
5th Mar 20139:09 amRNSTotal Voting Rights
18th Feb 20133:59 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.